Help provide individuals with neuromuscular diseases or injuries with leading edge technology, equipment and services.
Create a global conversation about ALS to ultimately find solutions and an end to the disease..
Raise public awareness toward ALS by providing and documenting extraordinary life adventures for individuals with muscular diseases or injuries.
The ALS Therapy Development Institute and its scientists actively discover and develop treatments for ALS. They are the world’s first and largest nonprofit biotech focused 100% on ALS research. Led by people with ALS and drug development experts, they understand the urgent need to slow and stop this disease.
Neuraltus Pharmaceuticals, Inc. is a privately held biopharmaceutical company dedicated to developing and commercializing therapeutics that address critical unmet needs in the treatment of neurodegenerative diseases. Their lead product, NP001, will complete Phase 2B at the end of 2017. They expect to seek approval with the FDA if study results support previous clinical trial findings.
Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. Their lead ALS products are Tirasemtiv and CK-107, both fast skeletal muscle troponin activators.